Peter Schuld
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 14
- Chronic Myeloid Leukemia Treatments 14
- Genetics 11
- Chronic Lymphocytic Leukemia Research 11
- Co-authors
- François‐Xavier Mahon (4 shared papers)Stéphane Bouchet (2 shared papers)Mathiéu Molimard (3 shared papers)R. Lassalle (1 shared paper)Nicholas Moore (1 shared paper)Karine Titier (1 shared paper)Coralie Bélanger (1 shared paper)Nicolas Widmer (1 shared paper)
- Journals
- Blood (5 papers)HemaSphere (2 papers)Cancer (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)Leukemia Research (1 paper)
- Partner nations
- GermanySwitzerlandFrance
In The Last Decade
Peter Schuld
11 papers receiving 199 citations
Peers
Comparison fields: 5 of 44
- Hematology 138
- Genetics 111
- Rheumatology 54
- Gastroenterology 14
- Pharmaceutical Science 14
Countries citing papers authored by Peter Schuld
This map shows the geographic impact of Peter Schuld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schuld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schuld more than expected).
Fields of papers citing papers by Peter Schuld
This network shows the impact of papers produced by Peter Schuld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schuld. The network helps show where Peter Schuld may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Schuld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 55 | |
| 2 | 2007 | 43 | |
| 3 | 2014 | 41 | |
| 4 | 2003 | 33 | |
| 5 | 2019 | 8 | |
| 6 | 2020 | 8 | |
| 7 | 2011 | 8 | |
| 8 | 2011 | 2 | |
| 9 | 2025 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2010 | 0 | |
| 13 | 2023 | 0 | |
| 14 | 2005 | 0 | |
| 15 | 2023 | 0 |
About Peter Schuld
Peter Schuld is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Rheumatology and Organic Chemistry, having authored 15 papers that have together received 201 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Lymphoma Diagnosis and Treatment (1 paper), Pharmaceutical studies and practices (1 paper), HER2/EGFR in Cancer Research (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Hematology (138 citations), Genetics (111 citations), Rheumatology (54 citations), Gastroenterology (14 citations) and Pharmaceutical Science (14 citations). Peter Schuld has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include François‐Xavier Mahon, Stéphane Bouchet, Mathiéu Molimard, R. Lassalle, Nicholas Moore, Karine Titier, Coralie Bélanger, Nicolas Widmer, Chantal Csajka and Thierry Buclin. Their work appears in journals such as Blood, HemaSphere, Cancer, Journal of Cancer Research and Clinical Oncology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.